The biopharma sector is seeing a proliferation of mergers, partnerships and acquisitions, but deals can sometimes fail due to poor scientific due diligence. Diane Seimetz and Jörg Schneider at Biopharma Excellence outline a plan of action to help you get the most from your business relationships.
We are now Cencora PharmaLex
PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.